Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Total Liabilities 2008–2025
Charles River Laboratories International, Inc. annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Charles River Laboratories International, Inc. total liabilities as of December 27, 2025: 3.92B, a 2.39% decrease year-over-year.
- Charles River Laboratories International, Inc. total liabilities for 2025 were 3.92B, a 2.39% decrease from 2024.
- Charles River Laboratories International, Inc. total liabilities for 2024 were 4.02B, a 11.37% decrease from 2023.
- Charles River Laboratories International, Inc. total liabilities for 2023 were 4.54B, a 0.94% decrease from 2022.
- Charles River Laboratories International, Inc. total liabilities for 2022 were 4.58B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Charles River Laboratories International, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3,924 |
| 2024 | $4,020 |
| 2023 | $4,536 |
| 2022 | $4,579 |
| 2021 | $4,432 |
| 2020 | $3,347 |
| 2019 | $3,026 |
| 2018 | $2,518 |
| 2017 | $1,866 |
| 2016 | $1,858 |
| 2015 | $1,303 |
| 2014 | $1,166 |
| 2013 | $968 |
| 2012 | $983 |
| 2011 | $1,031 |
Charles River Laboratories International, Inc. Total Liabilities — FAQ
Charles River Laboratories International, Inc. (CRL) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRL's total liabilities history?
The chart and table above show Charles River Laboratories International, Inc.'s total liabilities by year and by quarter, including the growth rate.